These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3975248)

  • 1. Central and peripheral contributions to the enhancement of amphetamine anorexia by desmethylimipramine (DMI).
    Towell A; Willner P; Booth DA
    Pharmacol Biochem Behav; 1985 Jan; 22(1):57-60. PubMed ID: 3975248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine.
    Willner P; Montgomery T
    Psychopharmacology (Berl); 1981; 75(1):54-9. PubMed ID: 6795661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats.
    Baptista T; Teneud L; Hernández L
    Pharmacol Biochem Behav; 1993 May; 45(1):45-9. PubMed ID: 8516371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of the anorexic effects of fenfluramine and amphetamine following intrahypothalamic injection.
    Blundell JE; Leshem MB
    Br J Pharmacol; 1973 Jan; 47(1):183-5. PubMed ID: 4717019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food intake and amphetamine anorexia after selective forebrain norepinephrine loss.
    Ahlskog JE
    Brain Res; 1974 Dec; 82(2):211-40. PubMed ID: 4374293
    [No Abstract]   [Full Text] [Related]  

  • 6. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
    Sanghvi IS; Singer G; Friedman E; Gershon S
    Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine.
    Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY
    J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine.
    Blundell JE; Leshem MB
    J Pharm Pharmacol; 1975 Jan; 27(1):31-7. PubMed ID: 235612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of desmethylimipramine on the appetite-lowering effects of d-amphetamine and other anorectics.
    Menon MK; Subramanian K; Menon NK; Sharma SN
    Eur J Pharmacol; 1970 Oct; 12(2):156-60. PubMed ID: 5472869
    [No Abstract]   [Full Text] [Related]  

  • 13. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats.
    Hsieh YS; Yang SF; Chen PN; Chu SC; Chen CH; Kuo DY
    J Psychopharmacol; 2011 Jul; 25(7):982-94. PubMed ID: 20817751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of receptor sensitivity changes in rat perifornical hypothalamus: a role for dopaminergic receptors in amphetamine anorexic tolerance.
    Bhakthavatsalam P; Kamatchi GL; Ghosh MN
    J Pharmacol Exp Ther; 1987 Jan; 240(1):196-202. PubMed ID: 3468240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of foot intake in the rat.
    Blavet N; DeFeudis FV
    Neurochem Res; 1982 Mar; 7(3):339-48. PubMed ID: 7110507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central action of anorexic agents: effects of amphetamine and fenfluramine in rats with lateral hypothalamic lesions.
    Blundell JE; Leshem MB
    Eur J Pharmacol; 1974 Sep; 28(1):81-8. PubMed ID: 4609778
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
    Brodie BB; Costa E; Groppetti A; Matsumoto C
    Br J Pharmacol; 1968 Nov; 34(3):648-58. PubMed ID: 5726793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the food intake suppression produced by giving amphetamine as an aversion treatment versus as an anorexic treatment.
    Carey RJ
    Psychopharmacology (Berl); 1978 Jan; 56(1):45-8. PubMed ID: 415326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic involvement in the locomotor stimulant or satiety action of thyrotropin-releasing hormone and amphetamine.
    Shian LR; Wu MH; Lin MT; Ho LT
    Pharmacology; 1985; 30(5):259-65. PubMed ID: 3923502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing tolerance to d-amphetamine-induced anorexia in rats.
    Milloy S; Glick SD
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):87-95. PubMed ID: 962432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.